T. A. Illingworth

Targeting hPKM2 in cancer: A bio isosteric approach for ligand design

Ludovico Pipitò, Giuseppe Deganutti, T. A. Illingworth, 2023, Comput. Biol. Medicine.

Development and validation of anti-human Alpha synuclein DNA aptamer using computer modelling techniques-an in silico study.

A. Alexiou, G. Batiha, G. Zouganelis, 2022, Journal of integrative neuroscience.

The formyl peptide receptor agonist FPRa14 induces differentiation of Neuro2a mouse neuroblastoma cells into multiple distinct morphologies which can be specifically inhibited with FPR antagonists and FPR knockdown using siRNA

A. Paterson, N. Milton, Margarita Gomez Escalada, 2019, PloS one.

Factors affecting COVID-19 vaccine uptake in populations with higher education: insights from a cross-sectional study among university students in Malawi

C. Mikeka, T. A. Illingworth, Qebo Kornelio Madhlopa, 2024, BMC infectious diseases.